A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer()

AIM: Anti-Müllerian hormone (AMH) shows promise as a biomarker of the ovarian reserve but current assays are insufficiently sensitive to allow assessment of this post-chemotherapy in most women. We have assessed a new highly sensitive AMH assay (Ansh picoAMH) in the evaluation of ovarian activity in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Joyce, Howie, A. Forbes, Cameron, David A., Anderson, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166459/
https://www.ncbi.nlm.nih.gov/pubmed/25027307
http://dx.doi.org/10.1016/j.ejca.2014.06.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166459/
https://www.ncbi.nlm.nih.gov/pubmed/25027307
http://dx.doi.org/10.1016/j.ejca.2014.06.011

Ejemplares similares